A case report of HER2 positive breast cancer traeted with inetetamab maintenance therapy
Breast cancer is one of the most common malignant tumors among women in the world,and its incidence and mortality are increasing year by year.Human epidermal growth factor receptor 2(HER2)positive breast cancer is a special type of breast cancer,which has a high degree of malignancy and is prone to metastasis.At present,targeted therapy has become an important treatment for HER2 positive breast cancer.This article reports on a patient with HER2-positive breast cancer.The patient developed left breast metastasis three years after modified radical mastectomy.Clinical palliative surgery was performed on the left breast cancer.Inetetamab was used for maintenance treatment for three years.At present,the condition is stable,and there is no serious adverse reaction after treatment.The curative effect can be expected.
万方数据
维普
